Bitcoin Looks Dead Now: Analysts See Moonshot Ahead
Bitcoin has pulled back from recent highs and trades near major support. Analysts debate whether the bottom is in, wi...
Using Index Level With Sentiment Indicators
Merging index levels with sentiment indicators can enhance conviction and risk controls. This piece provides actionable tips.
21,956 articles
Fund Dumps $6.5 Million SentinelOne Stake Amid Stock Slide
A prominent investor dumped $6.5 million of SentinelOne stock as the cybersecurity firm’s shares fell sharply. This a...
Rocket Lab Stock: Why Rocket Stock Rocketing Higher
Rocket Lab stock is catching strong momentum this week. We break down the key drivers behind the rally, what it means...
Bitcoin (And Peace) Trouble Deepens as Markets React
Bitcoin remains in focus as investors weigh new geopolitical flare-ups. Markets are pricing risk as bitcoin (and peac...
Brookdale Stock 200%, Fund: What It Means for Investors
When a fund exits its Brookdale Senior Living stake, it raises questions about momentum and risk. This guide breaks d...
Microsoft Stock Surging Today: What’s Driving the Rally
Microsoft stock is moving higher in a volatile market, defying a tech sell-off. This article breaks down the drivers ...
Amazon Retakes Lead Over SpaceX: 3 Reasons It Won't Last
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...
Kettle Hill Loads SentinelOne Amid Bold Stake Move
A notable hedge fund takes a sizable new position in SentinelOne, signaling growing confidence in AI-driven cybersecu...
Where Will Palantir Stock Be in 5 Years? A Forecast
This guide breaks down where will palantir stock could land in five years. You’ll find scenarios, risks, and actionab...
McGraw Hill Buys 22,000 Shares: Is This Bullish for MH Investors?
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
Can NVIDIA Shares Reach $500 by 2030? A Closer Look
NVIDIA stock hovers in the mid-$170s, as traders debate whether the company can reach $500 per share by 2030 through ...
This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status